Prognostic value of HIF-1α expression during fractionated irradiation
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic value of HIF-1α expression during fractionated irradiation
Authors
Keywords
-
Journal
STRAHLENTHERAPIE UND ONKOLOGIE
Volume 188, Issue 11, Pages 1031-1037
Publisher
Springer Nature
Online
2012-09-28
DOI
10.1007/s00066-012-0150-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Radiosensitization of Normoxic and Hypoxic H1339 Lung Tumor Cells by Heat Shock Protein 90 Inhibition Is Independent of Hypoxia Inducible Factor-1α
- (2012) Daniela Schilling et al. PLoS One
- Basal HIF-1α expression levels are not predictive for radiosensitivity of human cancer cell lines
- (2012) D. Schilling et al. STRAHLENTHERAPIE UND ONKOLOGIE
- Metabolic markers in relation to hypoxia; staining patterns and colocalization of pimonidazole, HIF-1α, CAIX, LDH-5, GLUT-1, MCT1 and MCT4
- (2011) Saskia E Rademakers et al. BMC CANCER
- Exploratory Study of the Prognostic Value of Microenvironmental Parameters During Fractionated Irradiation in Human Squamous Cell Carcinoma Xenografts
- (2011) Ala Yaromina et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Acute Versus Chronic Hypoxia: Why a Simplified Classification is Simply Not Enough
- (2011) Christine Bayer et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Small interfering RNA targeting HIF-1α reduces hypoxia-dependent transcription and radiosensitizes hypoxic HT 1080 human fibrosarcoma cells in vitro
- (2011) Adrian Staab et al. STRAHLENTHERAPIE UND ONKOLOGIE
- HIF-1α inhibition by siRNA or chetomin in human malignant glioma cells: effects on hypoxic radioresistance and monitoring via CA9 expression
- (2010) Jacqueline Kessler et al. BMC CANCER
- The Suppression of Hypoxia-inducible Factor and Vascular Endothelial Growth Factor by siRNA Does not Affect the Radiation Sensitivity of Multicellular Tumor Spheroids
- (2010) Yuefen ZOU et al. JOURNAL OF RADIATION RESEARCH
- Treatment regimen determines whether an HIF-1 inhibitor enhances or inhibits the effect of radiation therapy
- (2009) H Harada et al. BRITISH JOURNAL OF CANCER
- Molecular markers predict outcome in squamous cell carcinoma of the head and neck after concomitant cisplatin-based chemoradiation
- (2009) Guido B. van den Broek et al. INTERNATIONAL JOURNAL OF CANCER
- The selective hypoxia inducible factor-1 inhibitor PX-478 provides in vivo radiosensitization through tumor stromal effects
- (2009) D. L. Schwartz et al. MOLECULAR CANCER THERAPEUTICS
- Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
- (2009) G L Semenza ONCOGENE
- Core needle biopsies for determination of the microenvironment in individual tumours for longitudinal radiobiological studies
- (2009) Ala Yaromina et al. RADIOTHERAPY AND ONCOLOGY
- Lack of Hypoxic Response in Uterine Leiomyomas despite Severe Tissue Hypoxia
- (2008) A. Mayer et al. CANCER RESEARCH
- Detection and Specific Targeting of Hypoxic Regions within Solid Tumors: Current Preclinical and Clinical Strategies
- (2008) M. Bache et al. CURRENT MEDICINAL CHEMISTRY
- Prognostic Significance of Tumor Hypoxia Inducible Factor–1α Expression for Outcome After Radiotherapy in Oropharyngeal Cancer
- (2008) Priyamal Silva et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Immunohistochemical Detection of HIF-1α and CAIX in Advanced Head-and-Neck Cancer
- (2008) Matthias Kappler et al. STRAHLENTHERAPIE UND ONKOLOGIE
- Hypoxia inducible factor (HIF1α and HIF2α) and carbonic anhydrase 9 (CA9) expression and response of head-neck cancer to hypofractionated and accelerated radiotherapy
- (2007) Michael I. Koukourakis et al. INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started